Developer docs
API playgroundTry for free, no card

Search company profiles

NovoNutrients

Full company profile

uuid0000foc

Namestring
NovoNutrients
Company typeenum
Private
Founded yearint
2017
Descriptiontext

NovoNutrients is a synthetic biology startup founded in 2017 and based in Sunnyvale, California, that is developing an industrial fermentation platform to convert carbon dioxide emissions into protein powders suitable for human food, animal feed, and aquaculture applications. The company's core technology uses genetically engineered bacterial strains cultivated in bioreactors to perform CO2-to-protein bioconversion, producing protein that can be sold to food, ingredient, and feed manufacturers, as well as to industrial CO2 emitters such as cement and chemical plants that the company targets as both feedstock suppliers and commercial partners.

The company is currently building a pilot-scale plant intended to demonstrate the technology at industrial scale, produce validation samples for partners, and support commercial offtake negotiations. NovoNutrients has raised approximately $26 million across multiple funding rounds, including a $300,000 DOE grant in 2019, a $4.7 million round led by Happiness Capital in 2021, a $3 million development agreement with Woodside Energy in 2023, and an $18 million round co-led by CM Venture Capital and Woodside Energy in 2024. The company operates with a lean team of 1-10 employees.

The business model centers on B2B enterprise sales of protein powders derived from CO2, with the company targeting large industrial counterparties including food manufacturers, aquaculture feed companies, and industrial CO2 emitters. The go-to-market relies on strategic partnerships and co-located pilot plants at industrial partner sites rather than traditional marketing channels. Revenue from protein powder sales has not yet commenced at commercial scale, and pricing is not publicly disclosed.

Short descriptiontext

NovoNutrients is a Sunnyvale-based synthetic biology startup that uses proprietary fermentation and genetically engineered bacteria to convert industrial CO2 emissions into protein powders for food, animal feed, and aquaculture markets.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersSunnyvale, United States
HQ citystring
Sunnyvale
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Keyword5 values
alternative protein production, CO2 bioconversion, industrial fermentation, carbon capture utilization, aquaculture feed protein
Industry3 codes
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)
NAICS code1 code
  • Food Manufacturing311
SIC code1 code
  • Food And Kindred Products2000
Product category
Alternative Protein Manufacturing
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Protein Powder Sales
TypeHardware Sales
Description

Sale of protein powders produced from CO2 conversion for use in human food, animal feed, and aquaculture (fish consumption). The company produces protein products through industrial fermentation and sells them to food, feed, and ingredient manufacturers.

techcrunch.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Supply Chain, Infrastructure, Operations, Personnel
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

NovoNutrients runs an industrial fermentation platform that uses genetically engineered bacterial strains in bioreactors to convert industrial CO2 emissions into protein powders. The resulting proteins are intended for use in human food, animal feed, and aquaculture (fish feed). The company is scaling from pilot-plant validation toward industrial-scale production and targets industrial polluters such as cement and chemical plants as feedstock sources.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Significant reduction in industrial CO2 emissions
Product overview1 text field

NovoNutrients offers a single unified product platform focused on converting CO2 emissions into protein through industrial fermentation technology. Their core technology uses genetically engineered bacterial strains in bioreactors to transform carbon dioxide from industrial sources (such as cement and chemical plants) into protein powders. The company is scaling from pilot-scale operations toward industrial-scale production, targeting the alternative protein market for food, animal feed, and aquaculture applications.

Product and service1 record
1CO2-to-Protein Conversion Platform
CategoryAlternative Protein Production
Description

A proprietary industrial fermentation platform that converts carbon dioxide emissions into protein powders using genetically engineered bacterial strains cultivated in bioreactors. The protein powders are designed for human food, animal feed, and aquaculture applications, and the company is building pilot-scale facilities to scale toward industrial production.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers7 records
TypeDirect peer
Description

Air Protein converts CO2 from industrial emitters into single-cell protein using hydrogen-oxidizing bacteria. Directly comparable to NovoNutrients in feedstock, fermentation architecture, and target applications in food/feed.

TypeDirect peer
Description

Solar Foods produces Solein, a single-cell protein from CO2, water, and renewable electricity via gas fermentation. Most direct competitor to NovoNutrients given identical CO2-to-protein platform and overlap on food and feed end-markets.

TypeDirect peer
Description

Calysta produces FeedKind, a gas-fermented single-cell protein (methane-based) for aquaculture and animal feed. Comparable gas-fermentation alternative-protein platform targeting overlapping feed and aquaculture customers.

TypeDirect peer
Description

Deep Branch uses gas fermentation to convert CO2 and industrial gases into single-cell protein (Protin) for animal nutrition. Closest peer in terms of CO2 feedstock and feed-industry focus.

TypeBroad incumbent
Description

LanzaTech operates the largest commercial gas-fermentation platform in operation today, converting waste gases (CO, CO2) into fuels and chemicals via acetogen bacteria. Broader and better-capitalized incumbent in the same underlying gas-fermentation technology stack.

TypeEmerging player
Description

String Bio uses methane and gas fermentation (StringPro platform) to produce alternative protein and specialty ingredients. Comparable emerging gas-fermentation alternative-protein company, though primarily methane-fed rather than CO2.

TypeDirect peer
Description

Unibio produces Uniprotein via methane fermentation for aquaculture and animal feed. Comparable single-cell protein platform targeting the same aquaculture/feed customers as NovoNutrients.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature2 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles4 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds14 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors17 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

NovoNutrients

Alternative Protein Manufacturingnovonutrients.com

NovoNutrients is a Sunnyvale-based synthetic biology startup that uses proprietary fermentation and genetically engineered bacteria to convert industrial CO2 emissions into protein powders for food, animal feed, and aquaculture markets.

What NovoNutrients does

NovoNutrients is a synthetic biology startup founded in 2017 and based in Sunnyvale, California, that is developing an industrial fermentation platform to convert carbon dioxide emissions into protein powders suitable for human food, animal feed, and aquaculture applications. The company's core technology uses genetically engineered bacterial strains cultivated in bioreactors to perform CO2-to-protein bioconversion, producing protein that can be sold to food, ingredient, and feed manufacturers, as well as to industrial CO2 emitters such as cement and chemical plants that the company targets as both feedstock suppliers and commercial partners.

The company is currently building a pilot-scale plant intended to demonstrate the technology at industrial scale, produce validation samples for partners, and support commercial offtake negotiations. NovoNutrients has raised approximately $26 million across multiple funding rounds, including a $300,000 DOE grant in 2019, a $4.7 million round led by Happiness Capital in 2021, a $3 million development agreement with Woodside Energy in 2023, and an $18 million round co-led by CM Venture Capital and Woodside Energy in 2024. The company operates with a lean team of 1-10 employees.

The business model centers on B2B enterprise sales of protein powders derived from CO2, with the company targeting large industrial counterparties including food manufacturers, aquaculture feed companies, and industrial CO2 emitters. The go-to-market relies on strategic partnerships and co-located pilot plants at industrial partner sites rather than traditional marketing channels. Revenue from protein powder sales has not yet commenced at commercial scale, and pricing is not publicly disclosed.

NovoNutrients firmographics

Firmographics
Name
NovoNutrients
Website
https://novonutrients.com
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
1–10 employees
Short description
NovoNutrients is a Sunnyvale-based synthetic biology startup that uses proprietary fermentation and genetically engineered bacteria to convert industrial CO2 emissions into protein powders for food, animal feed, and aquaculture markets.
Ownership category
akta.pro rank

NovoNutrients industry classification

Industry
Product category
Alternative Protein Manufacturing
NAICS
Food Manufacturing (311)
SIC
Food And Kindred Products (2000)
akta.pro industry
PRIMARYAFAKAGAH
Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation)
Agriculture & Food Production/Food Processing & Manufacturing/Plant-Based & Alternative Protein Foods Manufacturing
SECONDARYEUAAAIAI
Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast)
Energy, Utilities & Environment/Bioenergy, Natural Gas & Biomass/Biorefining & Bio-based Chemicals (Co-products, Bioproducts)
SECONDARYCRADAOAI
Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts)

Keywords

  • Alternative protein production
  • CO2 bioconversion
  • Industrial fermentation
  • Carbon capture utilization
  • Aquaculture feed protein

Where NovoNutrients is headquartered

Location

Headquarters

HQ city
Sunnyvale
HQ country
United States
HQ region
North America

Markets served

NovoNutrients business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Supply Chain, Infrastructure, Operations, Personnel

Revenue model

  1. Protein Powder Sales: Sale of protein powders produced from CO2 conversion for use in human food, animal feed, and aquaculture (fish consumption). The company produces protein products through industrial fermentation and sells them to food, feed, and ingredient manufacturers.

Go-to-market motion1 record

Distribution channels1 record

NovoNutrients product offering

Product offering

Core offering

NovoNutrients runs an industrial fermentation platform that uses genetically engineered bacterial strains in bioreactors to convert industrial CO2 emissions into protein powders. The resulting proteins are intended for use in human food, animal feed, and aquaculture (fish feed). The company is scaling from pilot-plant validation toward industrial-scale production and targets industrial polluters such as cement and chemical plants as feedstock sources.

Product overview

NovoNutrients offers a single unified product platform focused on converting CO2 emissions into protein through industrial fermentation technology. Their core technology uses genetically engineered bacterial strains in bioreactors to transform carbon dioxide from industrial sources (such as cement and chemical plants) into protein powders. The company is scaling from pilot-scale operations toward industrial-scale production, targeting the alternative protein market for food, animal feed, and aquaculture applications.

Differentiator

Problem solved

Functional benefit

Products and services

  • CO2-to-Protein Conversion Platform A proprietary industrial fermentation platform that converts carbon dioxide emissions into protein powders using genetically engineered bacterial strains cultivated in bioreactors. The protein powders are designed for human food, animal feed, and aquaculture applications, and the company is building pilot-scale facilities to scale toward industrial production.

Quantifiable outcome

  • Significant reduction in industrial CO2 emissions

Companies that use NovoNutrients

Customer profile

Segments3 records

Ideal customer profiles3 records

NovoNutrients technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature2 records

NovoNutrients partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights5 records

NovoNutrients competitors and assessment

Company assessment

Direct peers

  • Air Protein: Air Protein converts CO2 from industrial emitters into single-cell protein using hydrogen-oxidizing bacteria. Directly comparable to NovoNutrients in feedstock, fermentation architecture, and target applications in food/feed.
  • Solar Foods: Solar Foods produces Solein, a single-cell protein from CO2, water, and renewable electricity via gas fermentation. Most direct competitor to NovoNutrients given identical CO2-to-protein platform and overlap on food and feed end-markets.
  • Calysta: Calysta produces FeedKind, a gas-fermented single-cell protein (methane-based) for aquaculture and animal feed. Comparable gas-fermentation alternative-protein platform targeting overlapping feed and aquaculture customers.
  • Deep Branch Biotechnology: Deep Branch uses gas fermentation to convert CO2 and industrial gases into single-cell protein (Protin) for animal nutrition. Closest peer in terms of CO2 feedstock and feed-industry focus.
  • Unibio: Unibio produces Uniprotein via methane fermentation for aquaculture and animal feed. Comparable single-cell protein platform targeting the same aquaculture/feed customers as NovoNutrients.

Broad incumbents

  • LanzaTech: LanzaTech operates the largest commercial gas-fermentation platform in operation today, converting waste gases (CO, CO2) into fuels and chemicals via acetogen bacteria. Broader and better-capitalized incumbent in the same underlying gas-fermentation technology stack.

Emerging players

  • String Bio: String Bio uses methane and gas fermentation (StringPro platform) to produce alternative protein and specialty ingredients. Comparable emerging gas-fermentation alternative-protein company, though primarily methane-fed rather than CO2.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks5 records

Key highlights6 records

Customer concentration

NovoNutrients social profiles

Digital presence

NovoNutrients financial estimates

Financial estimate

Revenue estimate

Valuation estimate

NovoNutrients leadership team

Management profile

Number of profiles

Profiles4 records

NovoNutrients funding detail

Funding detail

Funding overview

Funding rounds14 records

Investors17 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

NovoNutrients M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NovoNutrients

What does NovoNutrients do?

NovoNutrients runs an industrial fermentation platform that uses genetically engineered bacterial strains in bioreactors to convert industrial CO2 emissions into protein powders. The resulting proteins are intended for use in human food, animal feed, and aquaculture (fish feed). The company is scaling from pilot-plant validation toward industrial-scale production and targets industrial polluters such as cement and chemical plants as feedstock sources.

Is NovoNutrients a public or private company?

NovoNutrients is a private company. It is classified as venture growth investor backed and is currently operating.

When was NovoNutrients founded?

NovoNutrients was founded in 2017. It employs 1 to 10 people.

Where is NovoNutrients based?

NovoNutrients is headquartered in Sunnyvale, United States, in the North America region.

How does NovoNutrients make money?

One revenue line is on record: protein Powder Sales.

Who are NovoNutrients's main competitors?

Direct peers on record are Air Protein, Solar Foods, Calysta, Deep Branch Biotechnology and Unibio. LanzaTech is listed as a broad incumbent. String Bio is listed as an emerging player.

Does NovoNutrients have an API?

No public API is recorded for NovoNutrients.

What industry is NovoNutrients in?

NovoNutrients's product category is Alternative Protein Manufacturing. Its primary akta.pro industry code is AFAKAGAH, Fermentation-Derived Alternative Proteins Manufacturing (Precision Fermentation), with a secondary code of EUAAAIAI, Bio-based Animal Feed Ingredients & Nutrition Co-products (e.g., DDGS, protein meals, yeast). Its NAICS code is 311 and its SIC code is 2000.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Cultivated XBiosphere Adds CO2-to-Protein Technology With NovoNutrients DealCalifornia-based biomanufacturing company Biosphere has acquired NovoNutrients, a firm specializing in converting industrial CO2 and hydrogen into single-cell protein via gas fermentation. The acquisition grants Biosphere access to NovoNutrients' proprietary loop reactor technology and microbial strains, which are intended for food and feed applications. This move expands Biosphere's capabilities in high-intensity aerobic fermentation as it broadens its industrial bioproduction portfolio.GreenqueenBiosphere Acquires NovoNutrients to Strengthen Gas Fermentation PlatformUS biomanufacturing firm Biosphere has acquired the intellectual property and assets of gas fermentation specialist NovoNutrients, which entered an assignment for the benefit of creditors process in July 2025 due to capital intensity challenges. The acquisition combines Biosphere’s UV-sterilisation platform with NovoNutrients’ loop reactor technology to enhance scalable biomanufacturing infrastructure. This strategic move supports Biosphere's ongoing Department of Defense contracts for developing portable bioreactors for on-demand protein production.GlobeNewswireBiosphere Expands Biomanufacturing Platform with NovoNutrients AcquisitionBiosphere acquired NovoNutrients, a gas fermentation and reactor design company, to expand its biomanufacturing platform. The acquisition adds NovoNutrients' loop reactor technology, validated at multiple scales, to Biosphere's UV sterilization platform. It supports Biosphere's defense and industrial bioprocessing applications.The Fish SiteNovoNutrients abandons CO2-to-aquafeed dreamCalifornia-based startup NovoNutrients has entered an asset sale process via Assignment for the Benefit of Creditors, abandoning its plan to produce sustainable aquafeed from CO2. The company cited high capital intensity and a shifting investment climate as primary reasons for the wind-down, despite successfully validating its technology in pilot phases with 73% protein yields. Assets including patents, microbial strains, and equipment are now available for purchase by interested parties in the biotech sector.IndiebioNovoNutrientsNovoNutrients grows bacterial protein from industrial CO2 emissions for aquaculture feed. CEO David Tze says a cement plant's 4 million tons of CO2 could yield 2 million tons of protein meal, aiming for a gigaton solution.GreenqueenGas Protein Startup NovoNutrients to Sell Assets, Citing Investment ChallengesNovoNutrients, a California-based gas fermentation firm, has entered an assignment for the benefit of creditors process to sell its assets and intellectual property due to a challenging investment climate. The sale includes proprietary strains, patents, and pilot equipment developed over seven years, aiming to transfer technology to buyers in industrial biotech or alternative protein sectors. This event highlights broader funding struggles within the alternative protein industry, which saw significant declines in venture capital interest recently.AgFunderNewsGas fermentation startup Novonutrients calls it quits, seeks buyer for assets: ‘The technology’s potential remains unchanged’California-based gas fermentation startup NovoNutrients has entered the Assignment for the Benefit of Creditors process to sell its assets following financial difficulties. The company, which raised $18 million in a Series A round led by Woodside Energy, is seeking buyers for its proprietary technology and intellectual property before July 31. This move follows similar insolvency filings by competitor Arkeon, highlighting the capital-intensive challenges facing the gas fermentation sector.TmcnetNovoNutrients Raises US$18 million Series A led by Woodside Energy and co-led by CM Venture CapitalNovoNutrients raised US$18 million in a Series A led by Woodside Energy and co-led by CM Venture Capital, including US$10.3 million new capital and US$8 million in converted SAFEs. The funding will support its industrial pilot program, team growth, and commercial partnerships, with potential applications in pet food, aquaculture, and plant-based alternatives.PR NewswireNovoNutrients Raises US$18 million Series A led by Woodside Energy and co-led by CM Venture CapitalNovoNutrients raised $18 million in a Series A led by Woodside Energy and co-led by CM Venture Capital, including $10.3 million new capital and $8 million in SAFE conversions. The funding targets a total of $23 million and will support an industrial pilot program, team growth, and commercial partnerships for its CO₂-to-protein technology.TechCrunchNovoNutrients tweaks its bugs to turn CO2 into protein for people and petsNovoNutrients raised $18 million in a Series A round led by Woodside Energy and CM Venture Capital to build a pilot plant in the San Francisco Bay Area. The company will sell microbes and licenses for its CO2-to-protein technology, targeting pet food and human food markets.